Corporate Research, Sartorius Stedim Biotech GmbH, August-Spindler-Str. 11, 37079 Göttingen, Germany.
Corporate Research, Sartorius Stedim Biotech GmbH, August-Spindler-Str. 11, 37079 Göttingen, Germany.
J Biotechnol. 2022 Jun 20;352:16-25. doi: 10.1016/j.jbiotec.2022.05.004. Epub 2022 May 19.
Precipitation and flocculation pretreatments promise improved clarification of cell culture fluids (CCF) to intensify the production of monoclonal antibodies (mAb). However, such pretreatments pose the risks to alter the mAb and damage cells. This can be additionally exacerbated by the subsequent clarification process, for example by high shear forces during disk stack centrifugation, resulting in a release of host cell impurities. To overcome these limitations and enhance the clarification particularly of cell cultures with low viability and thus a high level of impurities, this study investigated low-pH precipitation and cationic polymer flocculation, each in combination with a mild fluidized bed centrifuge (FBC) separation and a subsequent filtration step. Therefore, low-viable CCF´s were pretreated and characterized to investigate the effects of additives on CCF composition and stability. In clarification experiments, both pretreatments achieved similar FBC throughput compared to an untreated reference but increased the maximum filter throughput up to four times. Furthermore, high mAb recoveries (> 91%), low turbidities (< 3.1 NTU) and high DNA removals (> 91%) were achieved. Similar glycan profiles and dimer ratios suggest consistent mAb quality. These findings have a great potential to intensify mAb downstream processing with both CCF pretreatments using a FBC clarification approach.
沉淀和絮凝预处理有望改善细胞培养上清液(CCF)的澄清度,从而强化单克隆抗体(mAb)的生产。然而,这些预处理方法存在改变 mAb 和损伤细胞的风险。随后的澄清过程,例如在碟片式离心机中高速剪切力的作用,会进一步加剧这种风险,导致宿主细胞杂质的释放。为了克服这些限制并提高澄清度,特别是对于存活率低且杂质水平高的细胞培养物,本研究调查了低 pH 沉淀和阳离子聚合物絮凝,分别结合温和流化床离心机(FBC)分离和随后的过滤步骤。因此,对低存活率的 CCF 进行预处理并进行了表征,以研究添加剂对 CCF 组成和稳定性的影响。在澄清实验中,与未经处理的对照相比,两种预处理方法的 FBC 处理量都相似,但最大过滤处理量提高了四倍。此外,实现了高 mAb 回收率(>91%)、低浊度(<3.1 NTU)和高 DNA 去除率(>91%)。相似的聚糖图谱和二聚体比例表明 mAb 质量一致。这些发现为使用 FBC 澄清方法进行 CCF 预处理的 mAb 下游处理强化提供了巨大的潜力。